GBA1 and Parkinson disease: GBA1 variants harbor a dose and variant‐type effect, with an earlier PD onset also reported in patients with biallelic (homozygous or compound heterozygous) GBA1 variants relative to heterozygotes,67 and in carriers of severe variants (5 years earlier) compared with mild variants.38, 68